Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation

Yansi Xian(Nanjing Drum Tower Hospital), Fangming Song(Guangxi Medical University), Yuangang Su(Guangxi Medical University), Jiamin Liang(Guangxi Medical University), Jiake Xu(Shenzhen Institutes of Advanced Technology), Yu Xiao(Guangxi University), Haoyu Lian(Guangxi Medical University), Qian Liu(Tongji University), Jinmin Zhao(Guangzhou University of Chinese Medicine), Xiaoliang Feng(Sichuan University), Feng Long(Gansu University of Traditional Chinese Medicine)
Biochemical Pharmacology
September 4, 2021
10.1016/j.bcp.2021.114761
Cited by 91

Related Papers

Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|588
Recent Advances in Optical Biosensors for Environmental Monitoring and Early Warning
|Sensors|2013|340
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species
|Theranostics|2019|252
Applications of magnetic nanoparticles in surface-enhanced Raman scattering (SERS) detection of environmental pollutants
|Journal of Environmental Sciences|2018|175
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
|Molecular Cancer|2009|131